Skip to Content


National Institute of Allergy and Infectious Disease; Notice of Closed Meeting

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy

Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel.

Date: August 30, 2000.

Time: 12:30 p.m. to 4:00 p.m.

Agenda: To review and evaluate contract proposals.

Place: 6700-B Rockledge Drive, Room 2148, Bethesda, MD 20892-7616 (Telephone Conference Call).

Contact Person: Robert C. Goldman, PhD, Scientific Review Administrator, Scientific Review Program, Divisions of Extramural Activities, NIAID, NIH, Room 2217, 67-B Rockledge Drive, MSC 7610, Bethesda, MD 20892-7610, 301 496-2550.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy Immunology, and Transplantion Research; 93.856, Microbiology and Infectious Diseases Reseach, National Institutes of Health, HHS)

Start Signature

Dated: August 1, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy.

End Signature End Preamble

[FR Doc. 00-20047 Filed 8-8-00; 8:45 am]